Veeco Instruments Inc. (VECO) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed

Updated Sep 22, 2026Q2 FY2026 reviewed

Veeco Instruments makes the semiconductor process equipment used to build AI accelerators, memory, and data-center optical lasers.

AP orders $200M

Advanced packaging orders in one quarter; mostly 2027 delivery.

InP orders $250M+

MOCVD, wet processing and ion beam orders for indium phosphide lasers.

Revenue +16.5% YoY

$193.5M in Q2 2026, above the midpoint of guidance.

FY26 EPS guide cut

Lowered to $1.36–$1.61 on spending ahead of 2027 capacity.

The Buildout Takeaway

Veeco is booking demand faster than it is shipping it — the two large order announcements are largely a 2027 story, and management is spending now to build the capacity that serves them. The question is whether that capacity, and its cost, land in the order they were promised.

Analyst coverage

36 analysts·19 Buy15 Hold2 Sell

Coverage is thin — only 1 price estimate, so no target is shown

Management guidance

FY2026 revenue $780–810M • gross margin 40–42% • non-GAAP diluted EPS $1.36–$1.61.

Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.

Our View

The Verdict

Veeco makes the process tools that deposit, etch, anneal, clean, pattern and coat thin films inside a chip or device line. That equipment sits at several points in the AI build-out: the back-end packaging steps that turn accelerators into multi-die packages, the annealing steps at leading-edge logic and memory, and the MOCVD, wet-processing and ion-beam tools used to make indium phosphide lasers that carry light between servers. Veeco does not make the chips, the packages or the optics — it sells the machines that the companies making those things buy.

Market Cap	—
Revenue (TTM)	$683M
Revenue Growth	−2.5%
EBITDA Margin (TTM)	6.9%

Net Cash	$172M
Earnings Beats	5 of 7
P/E (TTM)	—
EV/EBITDA (TTM)	—

What We Like

$250M+ of indium phosphide laser tool orders (Q1 2026) and $200M of advanced packaging orders (Q2 2026) — more than $450M across two quarters — against FY2026 revenue guidance of $780–810M.
The advanced packaging served market was raised from $650M by 2029 to about $1B by 2030.
Compound semiconductor revenue is guided to approximately double in FY2026, up from a ~50% growth expectation one quarter earlier.
Laser spike annealing is the production tool of record at all three Tier 1 logic customers, and nanosecond annealing is now engaged at all three, with one evaluation completed and a follow-on system ordered for H2 2026.
The balance sheet is net cash: $429M of cash and short-term investments against $257M of total debt as of 2026-06-30.

What We’re Watching

FY2026 revenue guidance was raised to $780–810M while non-GAAP EPS was lowered to $1.36–1.61 from $1.50–1.85; the ~$10M of incremental operating expense and ~75 basis points of gross-margin impact carry no stated split between one-time and recurring.
Most of the payoff is a 2027 event — the $200M advanced packaging order is principally 2027 delivery and the indium phosphide ramp is guided to begin in Q3 2026 — while $205.8M of purchase commitments come due within a year.
China: a BIS license requirement cost roughly $8M of Q1 2026 revenue, and China's share of revenue then rose from 13% in Q1 to 25% in Q2, with no resolution timeline given.
Two previously guided milestones went silent — the 45% second-half 2026 gross-margin target and the 2026 nanosecond annealing sign-off timeline.

Bottom Line

The thesis is strengthening on demand and weakening on near-term profitability at the same time. Order intake, backlog coverage and customer visibility all improved in the latest quarter, and the markets management describes are being echoed by the customers who buy Veeco's tools. Against that, the company cut its full-year earnings guidance while raising revenue guidance, and the payoff from both large order announcements sits in 2027. The open question is whether the capacity build produces that 2027 revenue on schedule and at the margins management describes, or whether the cost arrives first and the revenue later.

Next upQ3 2026 guidance puts revenue at $200–220M and gross margin at 41–42%, the next test of whether the second-half step-up is happening on schedule. Initial shipments against the $250M+ indium phosphide orders are also scheduled to begin in Q3 2026.

Last Quarter — Q2 FY2026

Earnings Beat

Veeco's Q2 2026 revenue was $193.5M, above the midpoint of its $170–190M guidance and up 16.5% from $166.1M a year earlier. Gross margin was 38.7%, and non-GAAP operating income was $23M. The standout metric was order intake in advanced packaging for wet processing and lithography systems in a single quarter, principally for 2027 delivery. Customer deposits rose $45M to $114M.

Metric	Q2 FY2026	Q1 FY2026	Q2 FY2025	YoY
Revenue	$194M	$158M	$166M	+16.5%
Gross margin	38.7%	34.8%	41.4%	-270bps
EBITDA	$17M	$6M	$18M	−4.0%
EPS	$0.18	$-0.00	$0.19	−8.3%
Advanced packaging orders	$200M	n/a	n/a	—
Customer deposits	$114M	n/a	n/a	—

During the second quarter, we secured $200 million in advanced packaging orders for wet processing and lithography systems, strengthening our visibility into 2027.— William Miller, CEO, 2026-08-05

Management tone: Management's language shifted from "a clear industry inflection point" in May to AI-driven demand accelerating "at an unprecedented pace" in August. The August call emphasized "significant backlog for 2027" and customers sharing forecasts "out beyond '27" — earlier and more emphatic forward visibility than the prior call. The guidance change, revenue up and earnings down, was framed repeatedly as deliberate investment ahead of 2027 rather than demand weakness. On the largest non-operational item, the pending Axcelis merger, management stated at the top of the call that it would not address related questions.

Management Guidance

For Q3 2026 management guided revenue of $200–220M and gross margin of 41–42%. For full-year 2026 it guided revenue of $780–810M (raised from $740–800M), full-year gross margin of 40–42%, and non-GAAP diluted EPS of $1.36–1.61 (lowered from $1.50–1.85). The full-year figures carry “approximately $10 million of incremental operating expenses and a gross margin impact of roughly 75 basis points” for the capacity build, described as including one-time setup costs, contract-manufacturer onboarding and hiring and training. Segment guidance: semiconductor more than 10% growth, compound semiconductor approximately double, and data storage double.

Business Trajectory

Trajectory

Revenue sat in a narrow band for four quarters — $166.1M, $165.9M, $165.0M and $158.3M from Q2 2025 through Q1 2026 — before stepping up to $193.5M in Q2 2026, up 16.5% year over year. Margins compressed across that stretch and then recovered off the Q1 2026 trough: reported gross margin went from 41.4% in Q2 2025 to 38.7% in Q2 2026, and from 34.8% in Q1 2026, while EBITDA margin moved from 4.0% in Q1 2026 back to 8.7% in Q2. Management attributes the step-up to mix — semiconductor revenue rose 20% sequentially on laser annealing to leading-edge logic and memory plus wet processing for advanced packaging, data storage rose 117% sequentially, and compound semiconductor rose 9%. Cash conversion has run ahead of reported earnings: trailing-twelve-month free cash flow was 186% of net income.

Revenue & Margin Trajectory

Gross margin as reported.

Share Price — 12 Months

52-week range $27–$75.

Share Price — 12 Months

52-week range $27–$75.

The Numbers

The Model

The model's locked projections put FY+1 revenue at $810M with EBITDA of $95M, an 11.7% margin, rising to FY+2 revenue of $1,100M with EBITDA of $185M, a 16.8% margin. The near-term anchor is the company's own guidance of $780–810M of revenue for the current year plus the more than $450M of orders already booked for 2027 delivery. The FY+2 step-up depends on that 2027 capacity coming online and on the build-related margin drag — roughly 75 basis points of gross margin alongside about $10M of incremental operating expense — not carrying forward.

Revenue & EBITDA Projections

Solid bars are reported actuals; outlined bars are model projections — not company guidance.

Metric	FY2025	Next FY (E)	Following FY (E)
Revenue	$664M	$810M	$1.1B
YoY Growth	—	+21.9%	+35.8%
EBITDA	$61M	$95M	$185M
EBITDA Margin	9.2%	11.7%	16.8%

Projections are the median of 5 independent model runs. The model’s revenue sits 4.9% above analyst consensus.

What Could Go Right — and Wrong

What good looks like

The advanced packaging and indium phosphide orders convert to revenue on the stated schedule, with the majority recognized in 2027.
SPECTOR IBD capacity reaches roughly 10x by early 2027 and advanced packaging and silicon photonics capacity more than doubles during 2027, keeping the ramp on plan.
Memory annealing converts: IBD300 moves from evaluation to purchase order, or the laser spike annealing evaluation at the second Tier 1 DRAM becomes pilot-line or high-volume orders in 2027–2028.
Compound semiconductor revenue approximately doubles in FY2026 as guided and accelerates into 2027 on Lumina MOCVD and SPECTOR IBD backlog.
Gross margin reaches the guided 41–42% in Q3 2026 and the roughly 75 basis points of build-related drag proves genuinely one-time.

What could go wrong

The 2027 capacity ramp slips after the cost is already in the income statement — the ~$10M of incremental operating expense, ~75 basis points of gross-margin impact, and $205.8M of purchase commitments substantially due within a year.
The margin dilution proves structural rather than one-time, leaving the guided 41–42% exit margin close to a ceiling for a larger manufacturing base.
China worsens — a further BIS-driven shipment interruption, or a Chinese response to the pending Axcelis transaction, lands on a geography that just rose to 25% of revenue.
Evaluation-stage programs stay evaluations: IBD300 extended again past end-2026, and the third Tier 1 nanosecond annealing sign-off never lands.
Concentration in a small set of unnamed customers grows further — the largest disclosed customer rose from 11% of revenue in FY2024 to 17% in FY2025.

What’s Next

Looking Ahead

The next twelve months are about conversion rather than new narrative. Initial indium phosphide shipments begin in Q3 2026, with management calling Q1 2027 the most significant ramp; the advanced packaging orders are principally a 2027 delivery. Data storage is booked well into 2027. SPECTOR IBD capacity is targeted to reach roughly 10x by early 2027, and advanced packaging and silicon photonics capacity is planned to more than double during 2027. Running alongside that, the Axcelis merger targets a close in the second half of 2026 with China antitrust approval outstanding, and full-year gross margin carries roughly 75 basis points of build-related drag.

Catalysts

Q3 2026InP orders begin shipping — Initial shipments against the indium phosphide orders.
H2 2026Axcelis merger close — Target close, pending China antitrust (SAMR) approval.
H2 2026NSA follow-on ships — Second nanosecond annealing system goes to a Tier 1 logic customer.
End 2026IBD300 DRAM evaluations — Evaluations extended through end-2026; conclusion or purchase order.
Early 2027SPECTOR capacity expands — Indium phosphide facet-coating capacity targeted at roughly 10x.
Q1 2027InP ramp accelerates — Management calls this the most significant ramp for InP orders.

Numbers

Financials

Annual Summary

Metric	FY2024	FY2025	TTM	YoY
Revenue	$717M	$664M	$683M	-7.4%
Gross Margin	42.4%	39.9%	37.8%	248bps
EBITDA	$92M	$61M	$47M	-33.9%
EBITDA Margin	12.8%	9.2%	6.9%	367bps
Net Income	$74M	$35M	$23M	-52.2%
Free Cash Flow	$46M	$53M	$85M	—
Net Cash	—	—	—	—

Key Ratios (Trailing)

Valuation

P/E TTM—
EV/EBITDA TTM—
EV/Revenue TTM—
Price/FCF TTM—

Profitability

Gross Margin (TTM)37.8%
EBITDA Margin (TTM)6.9%
Net Margin (TTM)3.4%
ROIC2.4%
FCF Conversion180.1%
SBC / Revenue3.9%

Reference

The Company

Veeco manufactures advanced semiconductor process equipment. In its own 10-K words, it “solves an array of challenging materials engineering problems for our customers,” combining ion beam, laser annealing, MOCVD, CVD, advanced packaging lithography, single wafer wet processing, MBE and ALD technologies that “play an integral role in the fabrication of key devices.” What ties that shelf together is that Veeco sells process steps rather than a platform — the tools that deposit, etch, anneal, clean, pattern or coat a film at a specific point in a customer's flow. The customer is a device maker, an outsourced assembly and test provider, or a laser and optical device line.

Veeco reports four end markets — Semiconductor, Compound Semiconductor, Data Storage, and Scientific & Other — from named sites including Plainview NY, Somerset NJ, St. Paul MN, San Jose CA, Horsham PA and Waltham MA. The sites the 10-K labels as manufacturing are Somerset NJ, St. Paul MN, San Jose CA and Horsham PA. Growth spending runs through internal East Coast manufacturing plus outsourcing to contract manufacturers in Southeast Asia.

Business Segments

Semiconductor

$131M in Q2 2026, 68% of revenue

Annealing for leading-edge logic and memory, ion beam deposition and etch, plus wet processing and advanced packaging lithography.

Growth driver: Advanced packaging orders; laser annealing at logic and memory

Compound Semiconductor

$21M in Q2 2026, 11% of revenue

MOCVD, wet processing and ion beam tools for indium phosphide lasers and GaN power devices.

Growth driver: Indium phosphide orders for AI optical interconnect

Data Storage

$22M in Q2 2026, 11% of revenue

Ion beam and wet processing tools for hard disk drive capacity and HAMR heads.

Growth driver: HAMR roadmaps; AI-driven demand for high-capacity HDDs

Competitive Landscape

The 10-K names principal competitors including Aixtron, Applied Materials, Canon, Mattson Technology, Screen Semiconductor Solutions and Suss MicroTec. Management has been unusually specific about where Veeco stands. In laser facet coating — the ion beam sputtering step — Miller described a “very strong incumbent position.” In wet processing he described a “strong position … with a number of the leaders.” In MOCVD epitaxy, where the source material describes Aixtron as the incumbent, he said Veeco is “probably more the second provider … as a second source.” The claim to durability in facet coating rests on Veeco's IBD technology being differentiated from traditional approaches as the industry moves to higher-powered lasers, which demand stricter film specifications.

Aixtron
10-K-named competitor. The source material describes Aixtron as the incumbent in MOCVD epitaxy, where management said Veeco is "probably more the second provider … as a second source."
Applied Materials
10-K-named principal competitor; the third-party wiring layer maps it to anneal and advanced packaging equipment.
Screen Semiconductor Solutions
10-K-named competitor; the wiring layer maps it to wet processing.
Mattson Technology
Named in filings; not discussed.
Suss MicroTec
Named in filings; not discussed.

Names are quoted from the 10-K's principal-competitor list; product-level mappings come from the third-party wiring layer and are directional. Canon is also named without discussion, and “Grand Plastics Technology” and “Shanghai Micro Electronics Equipment” are flagged in the intel file as likely OCR/transcription variants.

Supply Chain

Veeco sits upstream of the data center, selling tools that make the power and optical devices rather than data-center equipment itself. Among the neighbor companies in the evidence, only Axcelis, its pending merger counterparty, mentioned Veeco directly, pointing at MOCVD.

Supplier

Advanced Energy

RF power supplies, heating and temperature control for MOCVD and deposition.

Supplier

MKS Instruments

Gas delivery, power and plasma control subsystems.

Supplier

Entegris

Specialty gases, materials and contamination control.

Supplier

Coherent

Laser modules for laser spike annealing systems; also mapped as a customer for MOCVD reactors.